Acne Medication Market Upsurge Forecast Report 2028 with Latest Industry Developements

Acne is a skin condition that occurs when the hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. Effective acne treatments are available, but acne can be persistent. Depending on the severity of the acne, it can cause emotional distress and scar the skin. The earlier one starts the treatment, the lower is the risk of such problems. Four main factors that can cause acne include excess oil (sebum) production, hair follicles clogged by oil and dead skin cells, bacteria, and inflammation.

Global Acne Medication Market: Restraint

The major factor that hinder growth of the global acne medication market include side effects associated with acne drugs. For instance, the most common side effects of topical acne treatments are skin dryness and irritation. While some other side effects associated with acne drugs include dry, flaky, or peeling skin, tingly or irritated skin, skin redness, upset stomach, dizziness, lightheadedness, and increased sensitivity to the sun.

Comments

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth. Increasing preva...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

A biologic drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket .

Healthcare News

Search This Blog